Product Information

KURVELO-28 TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1215 per EA under NDC 68180084473. Its NADAC has been published 336 times since Jun 10, 2020.

FDA first approved this application on Oct 17, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

KURVELO-28 TABLET

levonorgestrel and ethinyl estradiol
$0.1215per EA

NDC

68180084473

Classification

Generic

Dosage Form

KIT

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA091408

FDA Approved

10/17/2012

TE Code

AB

On Market Since

2/7/2021

Price Statistics

The NADAC for KURVELO-28 TABLET has been published 336 times since Jun 10, 2020, and over the history we have for it it has declined 57.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1215 per EA
All-time high$0.2857 (Jun 10, 2020)
All-time low$0.0800 (Nov 20, 2024)
52-week high$0.1215
52-week low$0.1090
Median price$0.1510
Average price$0.1575
Largest weekly change+72.0% (Aug 21, 2024)
Weeks tracked336
Tracking sinceJun 10, 2020

Price History

1W

0.0%

1M

+7.1%

3M

+11.5%

6M

+3.5%

1Y

+8.2%

3Y

-27.3%

5Y

-42.3%

All

-57.5%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of KURVELO-28 TABLET?

The current National Average Drug Acquisition Cost (NADAC) for KURVELO-28 TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.1215 per EA (NDC 68180084473), effective Nov 11, 2026.

How has the price of KURVELO-28 TABLET changed over time?

Over the history we have for it, the NADAC for KURVELO-28 TABLET has declined 57.5%. It has been tracked across 336 weekly CMS publications since Jun 10, 2020.

What are the highest and lowest recorded NADAC prices for KURVELO-28 TABLET?

Since Jun 10, 2020, the NADAC for KURVELO-28 TABLET has ranged from a low of $0.0800 (Nov 20, 2024) to a high of $0.2857 (Jun 10, 2020), with a median of $0.1510 per EA.

Are there cheaper alternatives to KURVELO-28 TABLET?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVONOR-ETH ESTRAD 0.15-0.03, is $0.1128 per EA — about 7% below KURVELO-28 TABLET.

Who manufactures KURVELO-28 TABLET?

KURVELO-28 TABLET (NDC 68180084473) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.